| Rank |
Title |
Year |
PubWeight™‹?› |
|
101
|
In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargeting.
|
2012
|
0.79
|
|
102
|
Variability in myocardial metabolism on serial tumor (18)F-FDG PET/CT scans.
|
2014
|
0.79
|
|
103
|
PET/CT in the diagnosis of inflammatory bowel disease in pediatric patients: a review.
|
2014
|
0.79
|
|
104
|
Comparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myeloma.
|
2015
|
0.79
|
|
105
|
Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.
|
2014
|
0.79
|
|
106
|
Comparison of autologous (111)In-leukocytes, (18)F-FDG, (11)C-methionine, (11)C-PK11195 and (68)Ga-citrate for diagnostic nuclear imaging in a juvenile porcine haematogenous staphylococcus aureus osteomyelitis model.
|
2015
|
0.79
|
|
107
|
Cognitive reserve and clinical expression of Alzheimer's disease: evidence and implications for brain PET imaging.
|
2014
|
0.79
|
|
108
|
Efficacy of (99m)Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves' ophthalmopathy.
|
2012
|
0.79
|
|
109
|
Image quality assessment of automatic three-segment MR attenuation correction vs. CT attenuation correction.
|
2013
|
0.79
|
|
110
|
(18)F-FDG imaging of human atherosclerotic carotid plaques reflects gene expression of the key hypoxia marker HIF-1α.
|
2013
|
0.79
|
|
111
|
(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer.
|
2014
|
0.79
|
|
112
|
Added-value of SPECT/CT to lymphatic mapping and sentinel lymphadenectomy in gynaecological cancers.
|
2013
|
0.79
|
|
113
|
Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefway.
|
2014
|
0.79
|
|
114
|
Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5.
|
2011
|
0.79
|
|
115
|
Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents.
|
2014
|
0.79
|
|
116
|
Good manufacturing practice production of [(68)Ga]Ga-ABY-025 for HER2 specific breast cancer imaging.
|
2016
|
0.79
|
|
117
|
Comparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [(18)F]FDG and [(18)F]FLT.
|
2011
|
0.78
|
|
118
|
Revolutionizing (robot-assisted) laparoscopic gamma tracing using a drop-in gamma probe technology.
|
2016
|
0.78
|
|
119
|
Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.
|
2014
|
0.78
|
|
120
|
Development of a peptide by phage display for SPECT imaging of resistance-susceptible breast cancer.
|
2014
|
0.78
|
|
121
|
Biodistribution of the radionuclides (18)F-FDG, (11)C-methionine, (11)C-PK11195, and (68)Ga-citrate in domestic juvenile female pigs and morphological and molecular imaging of the tracers in hematogenously disseminated Staphylococcus aureus lesions.
|
2016
|
0.78
|
|
122
|
The normal variant (18)F FDG uptake in the lower thoracic spinal cord segments in cancer patients without CNS malignancy.
|
2013
|
0.78
|
|
123
|
A pilot study in epilepsy patients using simultaneous PET/MR.
|
2014
|
0.78
|
|
124
|
Regional, kinetic [(18)F]FDG PET imaging of a unilateral Parkinsonian animal model.
|
2013
|
0.78
|
|
125
|
Preoperative 123I-iomazenil SPECT imaging predicts cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis.
|
2011
|
0.78
|
|
126
|
Positron emission tomography imaging for vascular inflammation evaluation in elderly subjects with different risk factors for cardiovascular diseases.
|
2014
|
0.78
|
|
127
|
Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.
|
2012
|
0.78
|
|
128
|
The role of (18)F-FDG positron emission tomography in the follow-up of liver tumors treated with (90)Yttrium radioembolization.
|
2015
|
0.78
|
|
129
|
Effect of reconstruction algorithms on the accuracy of (99m)Tc sestamibi SPECT/CT parathyroid imaging.
|
2015
|
0.78
|
|
130
|
Interim analyses in diagnostic versus treatment studies: differences and similarities.
|
2012
|
0.78
|
|
131
|
Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.
|
2015
|
0.78
|
|
132
|
Synthesis and preclinical evaluation of a new C-6 alkylated pyrimidine derivative as a PET imaging agent for HSV1-tk gene expression.
|
2013
|
0.77
|
|
133
|
Separation of β-amyloid binding and white matter uptake of (18)F-flutemetamol using spectral analysis.
|
2015
|
0.77
|
|
134
|
FIAU: From reporter gene imaging to imaging of bacterial proliferation.
|
2012
|
0.77
|
|
135
|
Feasibility of (68)Ga-labeled Siglec-9 peptide for the imaging of acute lung inflammation: a pilot study in a porcine model of acute respiratory distress syndrome.
|
2016
|
0.77
|
|
136
|
Synthesis and in vivo evaluation of an (18)F-labeled glycoconjugate of PD156707 for imaging ETA receptor expression in thyroid carcinoma by positron emission tomography.
|
2013
|
0.77
|
|
137
|
Molecular imaging of integrin αvβ6 expression in living subjects.
|
2014
|
0.77
|
|
138
|
(18)F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison.
|
2012
|
0.77
|
|
139
|
Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma.
|
2014
|
0.77
|
|
140
|
Hippocampal MR spectroscopic abnormalities in a cohort of syphilitic patients with HIV and neurosyphilis infection.
|
2014
|
0.77
|
|
141
|
PET imaging of apoptosis in tumor-bearing mice and rabbits after paclitaxel treatment with (18)F(-)Labeled recombinant human His10-annexin V.
|
2014
|
0.77
|
|
142
|
The sweet spot: FDG and other 2-carbon glucose analogs for multi-modal metabolic imaging of tumor metabolism.
|
2014
|
0.77
|
|
143
|
Intrinsically radiolabelled [(59)Fe]-SPIONs for dual MRI/radionuclide detection.
|
2014
|
0.77
|
|
144
|
In vivo phage display selection of an ovarian cancer targeting peptide for SPECT/CT imaging.
|
2014
|
0.77
|
|
145
|
PET imaging of in vivo caspase-3/7 activity following myocardial ischemia-reperfusion injury with the radiolabeled isatin sulfonamide analogue [(18)F]WC-4-116.
|
2016
|
0.77
|
|
146
|
Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis.
|
2016
|
0.77
|
|
147
|
Targeting histone deacetylase in lung cancer for early diagnosis: (18)F-FAHA PET/CT imaging of NNK-treated A/J mice model.
|
2014
|
0.77
|
|
148
|
PET imaging of glioblastoma multiforme EGFR expression for therapeutic decision guidance.
|
2015
|
0.77
|
|
149
|
Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis.
|
2013
|
0.77
|
|
150
|
PET studies in epilepsy.
|
2015
|
0.77
|